Sec Form 4 Filing - Lefkowitz Steven W @ CorMedix Inc. - 2020-01-07

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Lefkowitz Steven W
2. Issuer Name and Ticker or Trading Symbol
CorMedix Inc. [ CRMD]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
C/O CORMEDIX INC., 400 CONNELL DRIVE, SUITE 5000
3. Date of Earliest Transaction (MM/DD/YY)
01/07/2020
(Street)
BERKELEY HEIGHTS, NJ07922
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/07/2020 X 4,500 A $ 4.5 59,776 D ( 1 )
Common Stock 01/07/2020 X 3,000 A $ 4.5 30,152 I ( 2 ) Wade Capital Corp Money Purchase Plan
Common Stock 2,000 I Reporting Person's Wife
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant (Right to Purchase Common Stock) $ 4.5 01/07/2020 X 4,500 01/08/2015 01/08/2020 Common Stock 4,500 $ 4.5 4,500 D
Warrant (Right to Purchase Common Stock) $ 4.5 01/07/2020 X 3,000 01/08/2015 01/08/2020 Common Stock 3,000 $ 4.5 3,000 I Wade Capital Corp Money Purchase Plan
Stock Option (Right to Buy Common Stock) $ 5.63 02/25/2020 A 15,000 ( 3 ) 02/25/2030 Common Stock 15,000 $ 5.63 15,000 D
Stock Option (Right to Buy Common Stock) $ 8.3 ( 4 ) 01/10/2029 Common Stock 15,000 15,000 D
Stock Option (Right to Buy Common Stock) $ 2.85 ( 5 ) 02/16/2028 Common Stock 8,000 8,000 D
Stock Option (Right to Buy Common Stock) $ 2.25 ( 6 ) 06/25/2027 Common Stock 15,000 15,000 D
Warrant (Right to Purchase Common Stock) $ 4.5 01/08/2015 01/08/2020 Common Stock 4,500 4,500 I ( 2 ) Wade Capital Corp Money Purchase Plan
Warrant (Right to Purchase Common Stock) $ 4.5 01/08/2015 01/08/2020 Common Stock 3,000 3,000 I ( 2 ) Wade Capital Corp Money Purchase Plan
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Lefkowitz Steven W
C/O CORMEDIX INC.
400 CONNELL DRIVE, SUITE 5000
BERKELEY HEIGHTS, NJ07922
X
Signatures
/s/ Steven W. Lefkowitz 02/27/2020
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Includes 24,963 shares held by the reporting person for the benefit of his minor son.
( 2 )The reporting person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which he has voting and investment control).
( 3 )These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
( 4 )These options were granted on 01/10/2019. The options are fully vested.
( 5 )These options were granted on 2/16/2018. These options are fully vested.
( 6 )These options were granted on 6/25/2017. These options are fully vested.

Remarks:
The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.